▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3630 by analyst upside · 2026-09-27
UHS
Universal Health Services, Inc.
Healthcare · Market Cap $11B · P/E 7.3x
ANALYST PRICE TARGET
+8.7%
implied upside to consensus target
Current Price $178.86
Consensus Target $194.35
Bull Target $290.0
Bear Target $166.0
Analysts Covering 17
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
5
Hold
10
Sell
1
52-Week Low $140.08
52-Week High $246.33
YTD Return -18.4%
FUNDAMENTALS
Market Cap $11B
P/E Ratio (TTM) 7.3x
Forward P/E 7.5x
EPS (TTM) $24.50
PEG Ratio 1.21
Dividend Yield 0.45%
Revenue (TTM) $18.1B
Profit Margin 8.4%
52-WEEK RANGE
52-Week Low $140.08
52-Week High $246.33
Current Price $178.86
Bear Target $166.0
Bull Target $290.0
● Now $178.86 ● Target $194.35
TRADING DATA
Avg Volume 841K
YTD Return -18.4%
Analyst Count 17
Consensus Hold
Upside to Target +8.7%
Last Updated 2026-09-27

ANALYST SUMMARY

Universal Health Services, Inc. (UHS) is currently trading at $178.86 with a Wall Street consensus price target of $194.35, implying potential upside of 8.7% over the next 12 months. 17 analysts currently cover UHS, with a consensus rating of Hold - 35% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $290.0, while the most cautious has a target of $166.0.

UHS operates in the Healthcare sector with a market capitalisation of $11B. The stock is down 18.4% year-to-date and is currently trading near the lower end of its 52-week range of $140.08 – $246.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

SNN +22.2%
Smith & Nephew plc
$11B · P/E 18.3x · Hold
FMS +11.7%
Fresenius Medical Care AG
$12B · P/E 12.0x · Hold
QGEN +4.7%
Qiagen N.V.
$9B · P/E 22.4x · Buy
GMED +38.5%
Globus Medical, Inc.
$10B · P/E 19.1x · Buy
PODD +26.3%
Insulet Corporation
$9B · P/E 25.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for UHS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners - Reiterated
Outperform → Outperform 2026-09-18 29% win rate (7 calls)
RBC Capital reit
Sector Perform → Sector Perform 2026-08-20 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-08-03 Building track record
Goldman Sachs - Reiterated
Neutral → Neutral 2026-07-30 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-07-29 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-07-29 62% win rate (8 calls)
Cantor Fitzgerald reit
Neutral → Neutral 2026-07-29 40% win rate (10 calls)
Baird - Reiterated
Neutral → Neutral 2026-07-29 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
22/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →